Humanigen requesting emergency use authorization for COVID-19 treatment

Morning After

MORNING AFTER (CW33/KDAF) — A company has just finished phase three trials of a monoclonal antibody treatment for COVID-19 and is requesting emergency use authorization for the treatment.

Chairman and CEO of the company Humanigen spoke with the Morning After crew about this treatment.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

More News Headlines

More

More From Morning After

More

Don't Miss

Popular

Latest News

More News